NCT00180817

Completed

Longitudinal Study of the Clinical and Haematological Cause ...

Imperial College London Source

Compare

Other study identifiers

Sponsor study identifier

EC3103

Study Type

observational

Estimated enrollment

250

Locations

1 country

Sites

1

Timeline

Study Start

September 1998

Actual (reported)

Primary Completion

August 31, 2005

Actual (reported)

Study Completion

August 31, 2005

Actual (reported)

Brief Summary

This study is being done to see if there are any long term health related issues in women with APA and recurrent miscarriages.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Estimated enrollment: 250 participants
Study completion date: August 31, 2005
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
September 1998
Actual (reported)
Primary Completion
August 31, 2005
Actual (reported)
Study Completion
August 31, 2005
Actual (reported)
First Submitted
September 13, 2005
Actual (reported)
First Posted
September 16, 2005
Actual (reported)

Last Updated: August 8, 2022
Status Verified: August 2022
Last Update Submitted: August 4, 2022

Conditions

Antiphospholipid Syndrome

Keywords

Antiphospholipid syndrome

Eligibility Criteria

Sexfemale

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Antiphospholipid syndrome History of recurrent miscarriages

You may not qualify if:

Previous thromboembolic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Imperial College London
Otherlead

Study Sites (1)

St. Mary's Hospital

London, W2 1NY, United Kingdom

MeSH Terms

Conditions

Antiphospholipid Syndrome

Condition Hierarchy (Ancestors)

Autoimmune DiseasesImmune System Diseases

Study Officials

Lesley Regan
Imperial College London
PRINCIPAL INVESTIGATOR
Raj Rai, MRCOG
Imperial College London
PRINCIPAL INVESTIGATOR
Winnie Lo
St. Mary's NHS Trust, London
PRINCIPAL INVESTIGATOR
Preeti Jindal, MRCOG
St. Mary's NHS Trust, London
PRINCIPAL INVESTIGATOR

Study Design

Study Type: observational
Time Perspective: OTHER
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 16, 2005

Study Start

September 1998

Actual (reported)

Primary Completion

August 31, 2005

Actual (reported)

Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome

Not Yet Recruiting

NCT00482794

Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

Recruiting

NCT00674297

Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients

Phase 2Completed

NCT00537290

A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome

Phase 2Completed

NCT07142239

Hematological Markers MPV, PLR, and NLR in Primary Versus Secondary Antiphospholipid Syndrome

Recruiting

NCT04153201

Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome

Not ApplicableCompleted

Study Completion

August 31, 2005

Actual (reported)

Last Updated

August 8, 2022

Record last verified: 2022-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00180817
Data provider: ClinicalTrials.gov
Source updated: 2022-08-08
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:33 UTC

Locations

GB(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

Source record

Locations